Key facts
- Notable investors include China Merchants Capital, Proxima Ventures (China), China Merchants Kunlun Capital, HuYangLin Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Bluesail Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Bluesail Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bluesail Surgical
Manufacturer of surgical instruments designed to enhance clinical precision, minimise invasiveness, and improve treatment outcomes. The company offers diversified surgical devices, innovative therapeutic technologies, and dedicated R&D and manufacturing capabilities, enabling global healthcare providers to deliver safer procedures, reduced complications, and superior patient prognoses.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- bluesailsurgical.com/
- Ownership
- Privately Held (backing)
Bluesail Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bluesail Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bluesail Surgical in its N-PORT filings yet. We sweep new filings monthly.